Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Complement Factor B
A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb.
Year introduced: 1999(1978)
Foxo1 protein, rat [Supplementary Concept]
Foxo1 plays important role in the establishment of the regional subdivision of the developing brain & in the development of the telencephalon; RefSeq NM_001191846
Date introduced: June 19, 1992
HLA-Bf antigen [Supplementary Concept]
Date introduced: April 25, 1986
BF 6 [Supplementary Concept]
Date introduced: June 20, 1985
Cytochrome b6f Complex
A protein complex that includes CYTOCHROME B6 and CYTOCHROME F. It is found in the THYLAKOID MEMBRANE and plays an important role in process of PHOTOSYNTHESIS by transferring electrons from PLASTOQUINONE to PLASTOCYANIN or CYTOCHROME C6. The transfer of electrons is coupled to the transport of PROTONS across the membrane.
Year introduced: 2004
cathelicidin BF, Bungarus fasciatus [Supplementary Concept]
amino acid sequence in first source
Date introduced: November 20, 2008
2-(2-(2-dimethylaminothiazol-5-yl)ethenyl)-6-(2-(fluoro)ethoxy)benzoxazole [Supplementary Concept]
a putative amyloid PET imaging probe; structure in first source
Date introduced: February 4, 2007
2-(4-aminophenyl)quinoline [Supplementary Concept]
used for imaging tau protein; structure in first source
Date introduced: March 5, 2006
2-((4-methylamino)phenyl)quinoline [Supplementary Concept]
4-(2-(2-benzoimidazolyl)ethenyl)-N,N-diethylbenzenamine [Supplementary Concept]
6-(2-fluoroethoxy)-2-(2-(4-methylaminophenil)ethenyl)benzoxazole [Supplementary Concept]
binds senile plaques in brain with Alzheimer's; structure in first source
Date introduced: May 26, 2004
(Cu(dppz)(2))BF(4) [Supplementary Concept]
synthesized by the reaction of [Cu(CH(3)CN)(4)]BF(4) and dipyrido[3,2-A:2',3'-c]phenazine (dppz); structure in first source
Date introduced: February 2, 2004
(Pt(MeNH(2))(2)(ChmT-N3)(TBDMS-ado-N1))BF(4) [Supplementary Concept]
ChmT = anion of 1-cyclohexylmethylthymine; TBDMS-ado = 2',3',5'-tri-tert-butyldimethylsilyladenosine; structure in first source
Date introduced: September 16, 2002
BF-2 compound [Supplementary Concept]
isolated from the dried leaves of Baeckea frutescens; structure given in first source; do not confuse with BF-2 (brain factor 2)
Date introduced: January 21, 1997
BF-1 compound [Supplementary Concept]
isolated from the dried leaves of Baeckea frutescens; structure given in first source; do not confuse with brain factor-1 (BF-1)
BF-7 diglycosyl diacylglycerol [Supplementary Concept]
structure given in first source
Date introduced: August 3, 1994
Biofor 389 [Supplementary Concept]
Date introduced: February 14, 1992
ibuprofen diethylaminoethyl ester [Supplementary Concept]
Date introduced: October 16, 1984
2-tert-butyl-4-chloro-5-(6-(4-fluorobutoxy)pyridin-3-ylmethoxy)-2H-pyridazin-3-one [Supplementary Concept]
a PET probe for mitochondrial complex I
Date introduced: April 27, 2014
Cbf-A7A13 peptide [Supplementary Concept]
a synthetic analog of Cathelicidin-BF
Date introduced: August 4, 2013